NCT02221323View on ClinicalTrials.gov

A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions

Diabetes Mellitus

Interventions

DRUG

Insulin LISPRO

Trial Locations (1)

41460

Profil Institut für Stoffwechselforschung GmbH, Neuss

All Listed Sponsors

lead

Profil Institut für Stoffwechselforschung GmbH

INDUSTRY

NCT02221323 - A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1 | Biotech Hunter | Biotech Hunter